Australia markets open in 7 hours 15 minutes

Vertex Pharmaceuticals Incorporated (0QZU.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
318.92-1.55 (-0.49%)
At close: 06:05PM GMT
Full screen
Previous close320.48
Open317.40
Bid0.00 x 0
Ask0.00 x 0
Day's range317.40 - 321.31
52-week range317.40 - 321.31
Volume230
Avg. volumeN/A
Market cap819.628M
Beta (5Y monthly)0.43
PE ratio (TTM)0.34
EPS (TTM)9.48
Earnings date24 Jan 2023 - 30 Jan 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Is This Biotech Stock a Buy Following a Landmark Approval?

    Provention Bio (NASDAQ: PRVB) is a small-cap biotech whose shares have doubled in the past three months. The company can thank the expected and eventual approval of Tzield for that performance. In mid-November, Tzield became the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for the delay of the onset of type 1 diabetes (T1D) in at-risk patients.

  • Simply Wall St.

    Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) five years ago are up 124%

    When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

  • Motley Fool

    3 Stocks to Buy Hand Over Fist in December

    Here's why they think that AbbVie (NYSE: ABBV), Exelixis (NASDAQ: EXEL), and Vertex Pharmaceuticals (NASDAQ: VRTX) are stocks to buy hand over fist in December. Prosper Junior Bakiny (AbbVie): The end of the year is always a great time to review your investment portfolio. The drugmaker is set to lose U.S. patent protection for its biggest cash cow -- autoimmune-disease medicine Humira -- next year.